Indian Stock Bulls Count on Earnings to Extend Best Winning Run Since November

India was hit with one of the highest tariff rates in Asia on its exports to the US, raising the risk of further losses in Indian equities; BSE screens showed falling stock prices on July 31, 2025. The tariff shock increases downside risk for export-sensitive sectors, is likely to spur risk-off investor positioning, and could widen market volatility across Indian markets.

Analysis

The tariff shock will transmit through three channels: (1) order-book compression for export-facing corporates (immediate margin shock), (2) FPI technical flows and stop-driven selling (days–weeks), and (3) slower capex and supply-chain reconfiguration (quarters–years). Expect an initial 2–5% rupee depreciation and FPI outflows on the order of $1–3bn over the first 2–4 weeks in a scenario similar to prior India trade shocks; that mechanically increases local currency debt servicing costs and compresses market liquidity, amplifying index moves beyond fundamental earnings impacts.

Second-order winners include domestically-oriented retailers, grocery/essentials and importers who see cheaper access to US markets for their inputs or win market-share at home; losers are mid-cap and SME exporters with concentrated US customer bases and thin hedges. Over 6–24 months the most durable effect is supply-chain relocation: ASEAN and South Asian competitors with lower US tariff exposure will capture share, forcing many Indian exporters into either margin compression or capital-intensive relocation — a capex drag on earnings and higher credit risk for banks with concentrated export-loan books.

Catalysts that could reverse this risk‑off phase are rapid diplomatic negotiations (weeks), tariff carve-outs or duty deferral programs (30–90 days), or RBI/DM interventions stabilizing FX and flows. Tail risks—escalation into broader goods or services tariffs, or retaliatory measures—would materially raise sovereign and banking sector tail risk and could trigger multi‑month outflows and rating pressure. The market reaction is partly sentiment-driven; absent protracted trade escalation, valuation overshoot is plausible and creates tactical re-entry points.

Key Decisions for Investors

• Tactical short India beta: Buy INDA (iShares MSCI India) 3‑month put spread — buy 5% OTM puts and sell 15% OTM puts sized to 2% of fund NAV. Thesis: 1–3 month directional hedge against a 6–12% India selloff; max loss = premium (~0.8–1.2% NAV), target payoff ~3–4x premium if INDA drops 8–12%. Exit/roll if rupee stabilizes within 2% or US provides carve-outs.
• Relative-value pair: Short export‑exposed large-midcap (example: SUNPHARMA) vs long domestic bank (HDFCBANK) for 3–6 months. Position size: net market‑neutral 50/50 notional; target 15–25% relative performance divergence. Rationale: exporters face direct margin/volatility hit and higher working capital; banks benefit from deposit inflows and higher domestic credit growth. Stop‑loss: 12% on either leg.
• Currency hedge for India exposure: Buy USD/INR 3‑month call options (or enter forwards) sized to cover 60–80% of India equity exposure. Cost ~1–2% of hedged notional; protects against 2–5% INR weakness and avoids forced liquidation in equity selloffs. Roll if realized FX move >2% or if FPI flows normalize.
• Opportunistic buy-on-capitulation rule: Add to a basket of exportable-value names (small-mid exporters) if they underperform Nifty by >20% within 3 months — stagger buys at 10%/30%/60% of target size and hold 6–12 months. Rationale: tariffs are frequently narrowed or negotiated; exporters typically hedge FX and can regain orders or pass some costs. Risk: sustained tariff regime or relocation costs >15% of EBITDA.